论文部分内容阅读
目的:探讨息斯敏治疗小儿喘息性支气管炎的临床效果。方法:随机选取我院收治的80例小儿喘息性支气管炎的患儿为研究对象,患者随机分为对照组和实验组,对照组40例,给予常规治疗,实验组40例,在对照组常规治疗基础上给予息斯敏治疗。两组患儿治疗后比较两组治疗效果。结果:对照组与实验组治疗前外周血嗜酸性粒细胞以及WBC等指标差异无统计学意义(P>0.05),治疗后,实验组各项指标明显低于对照组,差异具有统计学意义(P<0.05)。对照组与实验组治疗有效率为77.5%和92.5%,实验组显著高于对照组,差异具有统计学意义(P<0.05)。结论:息斯敏治疗小儿喘息性支气管炎疗效确切,值得在临床中推广应用。
Objective: To investigate the clinical effect of Astemizole on infantile asthmatic bronchitis. Methods: A total of 80 pediatric asthmatic bronchitis patients admitted to our hospital were selected randomly. The patients were randomly divided into control group, experimental group and control group, 40 cases were given routine treatment, 40 cases in experimental group, Astemizole treatment was given on the basis of treatment. Two groups of children after treatment, the treatment effect of two groups were compared. Results: There were no significant differences in eosinophil and WBC before treatment between control group and experimental group (P> 0.05). After treatment, the indexes in experimental group were significantly lower than those in control group (P <0.05) P <0.05). The effective rates of the control group and the experimental group were 77.5% and 92.5%, respectively, which were significantly higher in the experimental group than those in the control group (P <0.05). Conclusion: Astemizine treatment of infantile asthmatic bronchitis is effective and worthy of promotion and application in clinic.